Three scientists win 2026 Nobel Prize in Medicine for optogenetics breakthrough

Karl Deisseroth, Peter Hegemann and Georg Nagel have won the 2026 Nobel Prize in Physiology or Medicine for their discoveries concerning light-gated ion channels and optogenetics.

The Discovery

Announced on October 5, 2026, the award includes a prize amount of 12 million Swedish kronor to be shared equally between the three laureates. The work began with Peter Hegemann studying how a single-celled alga swims toward light. Georg Nagel then discovered channelrhodopsin, an algal protein on the cell surface that opens a channel when illuminated by blue light, allowing charged ions to flow in and create an electrical impulse. Karl Deisseroth subsequently transformed this protein into a light-controlled switch for nerve cells. In 2005, Hegemann and Deisseroth introduced the gene for channelrhodopsin into rat nerve cells and triggered a signal using blue light, before making it work in the brains of living mice two years later. This year's Nobel win beat other favourites including GLP-1 drugs and CAR-T therapies.

How It Works

Optogenetics combines genetic targeting and optical control in neural circuits. Scientists use harmless viral vectors to deliver genes for light-sensitive proteins like opsins into specific target cells. Researchers then deliver precise pulses of light using tiny fiber-optic cables or LEDs. Depending on the opsin used, the light either opens channels to excite and activate the cell or pumps ions to silence it.

Context

Optogenetics allows researchers to map brain functions and neural circuits related to memories, feelings, and behaviours in ways that older mapping methods could not prove causally. In clinical medicine, the technique is also being tested to help restore sight in people with visual impairments.